Chandra Kirana

Adelaide Medical School

Faculty of Health and Medical Sciences


My Research :Dr Chandra Kirana's research interest focus on finding biomarkers for bowel cancer patients using proteomic approaches. Almost 90% of bowel cancer patients died from metastatic dissemination mostly to the liver. Protein biomarkers are urgently required to support current methodologies to improve accuracy in stratifying patients into low and high risk of metastasis so that accurate disease management will be given to the patients to increase survival. In addition, she is also interested in using the concept of "seed and soil" to understand the mechanism of metastatic dissemination of colorectal cancer to the liver. Her work equipped with a large number of samples from bowel cancer patients completed with clinical parameters of the patients and the histology of tumours. She also has experience in isolation and identification of bio-active compounds from medicinal plants using various chromatographic and spectrophotometric techniques. Her previous work involved using small animals to assess efficacy of active compounds isolated from medicinal plants including AOM-induced colon cancer and DSS-induced inflammatory bowel disease model study. Collaborations:Clinicians at The Queen Elizabeth Hospital and Royal Adelaide HospitalMr John Keating, Wellington Hospital, Wellington, New ZealandProfessor Richard Stubbs, P3 Research, Wellington, New ZealandDr Lifeng Peng, Centre for Biodiscovery, School of Biological Sciences, Victoria University of Wellington, Wellington, New ZealandDr Andrea Bubendorfer, Callaghan Innovation, New Zealand's Innovation Agency, Wellington, New ZealandConsumer Engagement:Cancer Voices SA

I have been working on Sjogren Disease in the last 5 years.  Sjogren Disease (SjD), a systemic autoimmune rheumatic disease, characterized mainly by diminished function of the lacrimal, salivary glands and mucosal surfaces leading to dry eyes, dry mouth and dryness of other organs. The majority of patients with SjD manifested features of other organ inflammation including arthritis, interstitial lung disease, tubulointerstitial nephritis and lymphoma, which is life-threatening. Diagnosis of SjD is not very straight forward due to various symptoms. Early detection of SjD is very crucial to prevent severe organ manifestations. The pathogenesis of SjD remains unknown. The SjD projects aim to collect detailed medical information including serological data and biological samples of patients who diagnosed with SjD and met 2016  ACR-EULAR classification Criteria and consented for the study. Data and biobank samples of participants are collected at baseline and annual visit at Rheumatology Unit at TQEH, to further understand the pathogenesis of disease. Patient's impacted quality of life is also studied by participant's self reported using questionnaires incluing Compas 31, SF36, FACIT Fatique Scale, ESSPRI, AUA SS, OSDI, Epworth Sleepiness Scale.

Date Position Institution name
2018 - ongoing Senior Research Officer University of Adelaide
2014 - 2018 Research Officer University of Adelaide, Adelaide
2007 - 2018 Postdoctoral Fellow Wakefield Biomedical Research Institute
2003 - 2006 Postdoctoral Fellow Diet & nutrition (CSIRO), Adelaide
1989 - 1999 Lecturer Brawijaya University

Language Competency
English Can peer review
Indonesian Can peer review

Date Institution name Country Title
1999 - 2003 University of Adelaide, Adelaide Australia PhD
1993 - 1996 University of Adelaide, Adelaide Australia MAgSc
Gadjah Mada University Indonesia Bsc (Hons) (Biology)

Year Citation
2023 Krishnan, S. T., Winkler, D., Creek, D., Anderson, D., Kirana, C., Maddern, G. J., . . . Voelcker, N. H. (2023). Staging of colorectal cancer using lipid biomarkers and machine learning.. Metabolomics, 19(10), 11 pages.
DOI Scopus13 WoS12 Europe PMC10
2020 Kirana, C., Smith, E., Ngo, D. T., Trochsler, M. I., Hewett, P. J., Stubbs, R. S., . . . Hauben, E. (2020). High preoperative levels of circulating SFRP5 predict better prognosis in colorectal cancer patients.. Future Oncol, 16(31), 2499-2509.
DOI Scopus9 WoS9 Europe PMC8
2019 Kirana, C., Peng, L., Miller, R., Keating, J. P., Glenn, C., Shi, H., . . . Stubbs, R. S. (2019). Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread. Clinical Proteomics, 16(1), 13 pages.
DOI Scopus33 WoS29 Europe PMC21
2017 Kirana, C., Ruszkiewicz, A., Stubbs, R., Hardingham, J., Hewett, P., Maddern, G., & Hauben, E. (2017). Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages. International Journal of Cancer, 140(11), 2577-2586.
DOI Scopus32 WoS27 Europe PMC21
2017 Miljkovic, D., Ou, J., Kirana, C., Hulse, K., Hauben, E., Psaltis, A., . . . Vreugde, S. (2017). Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis. International Forum of Allergy and Rhinology, 7(6), 609-614.
DOI Scopus4 WoS4 Europe PMC2
2013 Shi, H., Hayes, M., Kirana, C., Miller, R., Keating, J., & Stubbs, R. (2013). Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Human Pathology, 44(6), 1089-1097.
DOI Scopus16 WoS16 Europe PMC17
2012 Kirana, C., Shi, H., Laing, E., Hood, K., Miller, R., Bethwaite, P., . . . Stubbs, R. (2012). Cathepsin D expression in colorectal cancer: from proteomic discovery through validation using western blotting, immunohistochemistry, and tissue microarrays. International journal of proteomics, 2012, 1-11.
DOI Europe PMC20
2012 Shi, H., Hayes, M., Kirana, C., Miller, R., Keating, J., MacArtney-Coxson, D., & Stubbs, R. (2012). TUFM is a potential new prognostic indicator for colorectal carcinoma. Pathology, 44(6), 506-512.
DOI Scopus30 WoS28 Europe PMC25
2009 Kirana, C., Ward, T., Jordan, T. W., Rawson, P., Royds, J., Shi, H. J., . . . Hood, K. (2009). Compatibility of toluidine blue with laser microdissection and saturation labeling DIGE. Proteomics, 9(2), 485-490.
DOI Scopus13 WoS12 Europe PMC11
2007 Kirana, C., Jones, G., Record, I., & McIntosh, G. (2007). Anticancer properties of panduratin A isolated from Boesenbergia pandurata (Zingiberaceae). Journal of Natural Medicines, 61(2), 131-137.
DOI Scopus68 WoS51
2005 Kirana, C., Rogers, P. F., Bennett, L. E., Abeywardena, M. Y., & Patten, G. S. (2005). Naturally derived micelles for rapid in vitro screening of potential cholesterol-lowering bioactives. Journal of Agricultural and Food Chemistry, 53(11), 4623-4627.
DOI Scopus68 WoS54 Europe PMC36
2003 Kirana, C., McIntosh, G., Record, I., & Jones, G. (2003). Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutrition and Cancer-An International Journal, 45(2), 218-225.
DOI Scopus116 WoS95 Europe PMC59
2003 Kirana, C., Record, I., McIntosh, G., & Jones, G. (2003). Screening for antitumor activity of 11 species of Indonesian Zingiberaceae using human MCF-7 and HT-29 cancer cells. Pharmaceutical Biology, 41(4), 271-276.
DOI Scopus63 WoS45

Year Citation
2019 Sulaiman, R., Isnanto, B., Ki, H., & Kirana, C. (2019). Cryptography in (LSB) method using rc4 algorithm and aes algorithm in digital image to improve message security. In Proceedings - 2018 4th International Conference on Computing, Engineering, and Design, ICCED 2018 (pp. 29-34). online: IEEE.
DOI Scopus2
2018 Kirana, C. (2018). Communication between mothers and children about environmental issues (a study about the role of mothers to educate their children on keeping a clean environment). In E3S Web of Conferences Vol. 74 (pp. 1-7). online: EDP Sciences.
DOI Scopus3
2005 Kirana, C., Rogers, P. F., Bennett, L. E., Abeywardena, M. Y., & Patten, G. S. (2005). Rapid screening for potential cholesterol-lowering peptides using naturally derived micelle preparation. In Australian Journal of Dairy Technology Vol. 60 (pp. 163-166). AUSTRALIA, Adelaide: DAIRY INDUSTRY ASSOC AUSTRALIA.
Scopus8 WoS7

N/A

N/A

Date Role Committee Institution Country
2017 - ongoing Member TQEH Strategic Research Direction The Queen Elizabeth Hospital - Basil Hetzel Research Institute Australia
2016 - ongoing Member The Institute (BHI) Policy Committee Basil Hetzel Institute Australia
2015 - ongoing Co-Chair The Institute (Basil Hetzel Institute) Management Committee Basil Hetzel Research Institute Australia

Connect With Me

External Profiles

Other Links